IME.AX ImExHS ASX pre-market 19 Mar 2026: Volume spike 231,944, watch 0.47

A pre-market volume spike has hit IME.AX stock this morning. ImExHS Limited (ASX: IME) shows 231,944 shares traded versus an average daily volume of 12,526, giving a relative volume of 18.52. The stock opened at A$0.42 and sits at A$0.40 with a day high of A$0.43. The jump follows the FY25 results that reported revenue growth and a large EBITDA lift. Traders using a volume-spike strategy should watch intraday confirmation before adding risk, and note our model projection for near-term upside.

Pre-market volume spike and price action

IME.AX stock shows a clear volume event in pre-market trade. Volume is 231,944 versus average 12,526, a spike that often precedes short-term moves. Price is A$0.40, day range A$0.39–A$0.43, year high A$0.47. Watch whether volume sustains above 50,000 on the open to confirm momentum.

Catalyst: FY25 results and recent IME.AX news

Management flagged FY25 revenue improvement and a sharp EBITDA lift. Investing.com covered the FY25 presentation and the numbers appear to be driving interest source. One clear claim: FY25 commentary is the primary trigger for the volume spike in pre-market trade.

Fundamentals, valuation and Meyka AI grade

ImExHS has market cap A$21,620,274.00 and EPS -A$0.06 with PE -6.67. Key ratios: P/S 0.75, P/B 1.36, current ratio 1.73, cash per share A$0.06. Meyka AI rates IME.AX with a score out of 100: 69.91 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus.

Technical read and price targets for traders

Technicals show neutral momentum. RSI 43.47, ADX 27.06 and 50-day average A$0.42 vs 200-day A$0.32. Immediate resistance sits near the year high A$0.47. A conservative price target is A$0.50 (quarter view). Downside support is A$0.30. These targets use current liquidity and recent volatility as inputs.

Risks, sector context and IME.AX outlook

Risks include negative net income, stretched receivables days 117.69, and low free cash flow yield 0.01. The Healthcare sector in Australia shows mixed performance versus benchmarks. Catalysts that could reduce risk are new teleradiology contracts and adoption of STELLA.I AI tools. Monitor sector moves and regulatory updates for healthcare IT.

Trading idea: volume-spike strategy on IME.AX stock

For pre-market volume spikes, wait for volume confirmation on the open. Entry suggestion: buy on a sustained break above A$0.43 with volume over 50,000. Place a stop-loss near A$0.34 to limit downside. Use position size that limits portfolio risk to 1–2%. See live quote at Meyka IME.AX and related market context source.

Final Thoughts

The immediate fact: IME.AX stock is trading with an unusually high pre-market volume of 231,944 shares, signaling trader interest after FY25 results. Fundamentals show growth in revenue but continued negative EPS -A$0.06. Meyka AI’s forecast model projects a near-term quarterly target of A$0.50 versus the current A$0.40, implying an upside of 25.00%. This projection is model-based and not a guarantee. Short-term traders should seek volume confirmation above A$0.43 before entering, and position size to limit risk. Investors should weigh sector dynamics and the company’s cash metrics before adding exposure. Meyka AI provides this as AI-powered market analysis to inform risk-managed decisions.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.